No need for the needle (at First)

Diabetes Care

Volumn 31, Issue 10, 2008, Pages 2070-2071

  Davidson, Mayer B ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLICLAZIDE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ANTIDIABETIC AGENT;

CELL FUNCTION; DIABETES MELLITUS; EDITORIAL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; DIET RESTRICTION; HOSPITALIZATION; NEEDLE; NOTE; ORAL DRUG ADMINISTRATION; PATIENT EDUCATION;

ADMINISTRATION, ORAL; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; NEEDLES; PATIENT EDUCATION AS TOPIC;

EID: 56149096997     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1283     Document Type: Editorial

References (14)

1. Chen H-S, Wu T-E, Jap T-S, Hsiao L-C Lee S-H, Lin H-D: Beneficial effects of insulin on glycemic control and ß-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy. Diabetes Care 31:1927-1932, 2008
2. Nathan DM, BuseJB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B: Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 29:1963-1972, 2006
3. Kilpatrick ED, Robertson RP: Differentiation between glucose-induced desensiti-zation of insulin secretion and ß-cell exhaustion in the HIT-T15 cell line. Diabetes 47:606-611, 1998
4. lc) to the risk of development and progression of ret-inopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
5. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbumin-uria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1995
6. Warram JH, Scott LJ, Hanna LS, Want-man M, Cohen SE, Laffel LMB, Ryan L Krolewski A: Progression of microalbu-minuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia. Diabetes 49:94-100, 2000
7. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, KojimaY, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvas-cular complications in Japanese patients with non-insulin-dependent diabetes melli-tus: a randomized prospective 6-year study. Diabetes Res Clín Pract 28:103-117, 1995
8. TanakaY, AtsumiY,MatsuokaK,OnumaT, Tohjima T, Kawamori R: Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients. Diabetes Care 21:116-120, 1998
9. Ilkova H, Glaser B, Tunckale A, Bagriacik N, Cerasi E: Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 20:1353-1356, 1997
10. Park S, Choi AB: Induction of long-term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insulin infusion therapy. Metab Res Rev 19:124-130, 2003
11. Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, Hu G, WengJP: Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of ß-cell function. Diabetes Care 27:2597-2602, 2004
12. WengJ, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H: Effect of intensive insulin therapy on ß-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomized parallel-group trial. Lancet 371:1753-1760, 2008
13. Ryan EA, Imes S, Wallace C: Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 27: 1028-1032, 2004
14. Brown JB, Nichols GA, Perry A: The burden of treatment failure in type 2 diabetes. Diabetes Care 27:1535-1540, 2004